TY  - JOUR
AU  - Roth-Walter, Franziska
AU  - Adcock, Ian M
AU  - Benito-Villalvilla, Cristina
AU  - Bianchini, Rodolfo
AU  - Bjermer, Leif
AU  - Boyman, Onur
AU  - Caramori, Gaetano
AU  - Cari, Luigi
AU  - Fan-Chung, Kian
AU  - Diamant, Zuzana
AU  - Eguiluz-Gracia, Ibon
AU  - Knol, Edward F
AU  - Kolios, Antonios
AU  - Levi-Schaffer, Francesca
AU  - Nocentini, Giuseppe
AU  - Palomares, Oscar
AU  - Redegeld, Frank
AU  - Van-Esch, Betty
AU  - Stellato, Cristiana
PY  - 2021
DO  - 10.1111/all.14478
UR  - http://hdl.handle.net/10668/15840
T2  - Allergy
AB  - Therapeutic advances using targeted biologicals and small-molecule drugs have achieved significant success in the treatment of chronic allergic, autoimmune, and inflammatory diseases particularly for some patients with severe, treatment-resistant...
LA  - en
PB  - Wiley
KW  - CAR-Treg cells
KW  - Adoptive cell therapies
KW  - Allergy
KW  - Autoimmunity
KW  - Immunoregulation
KW  - Asthma
KW  - Autoimmune Diseases
KW  - Humans
KW  - Hypersensitivity
KW  - T-Lymphocytes, Regulatory
TI  - Immune modulation via T regulatory cell enhancement: Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases-An EAACI position paper of the Task Force on Immunopharmacology (TIPCO).
TY  - research article
VL  - 76
ER  -